Clinical Trial Update: Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting termination of sequential tranylcypromine-based regimens for refractory depression (tranylcypromine alone, with dextroamphetamine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Dextroamphetamine (Dextroamphetamine)
• Tranylcypromine (tranylcypromine)
• Triiodothyronine (liothyronine sodium)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Major Depression | Phase 4 | Status: TERMINATED